303 related articles for article (PubMed ID: 15572168)
1. Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain.
Bustos G; Abarca J; Campusano J; Bustos V; Noriega V; Aliaga E
Brain Res Brain Res Rev; 2004 Dec; 47(1-3):126-44. PubMed ID: 15572168
[TBL] [Abstract][Full Text] [Related]
2. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
[TBL] [Abstract][Full Text] [Related]
3. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
Lavoute C; Weiss M; Rostain JC
Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
[TBL] [Abstract][Full Text] [Related]
4. Limited regulation of somatodendritic dopamine release by voltage-sensitive Ca channels contrasted with strong regulation of axonal dopamine release.
Chen BT; Moran KA; Avshalumov MV; Rice ME
J Neurochem; 2006 Feb; 96(3):645-55. PubMed ID: 16405515
[TBL] [Abstract][Full Text] [Related]
5. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
Lavoute C; Weiss M; Rostain JC
Brain Res; 2007 Oct; 1176():37-44. PubMed ID: 17900538
[TBL] [Abstract][Full Text] [Related]
6. NMDA-mediated release of glutamate and GABA in the subthalamic nucleus is mediated by dopamine: an in vivo microdialysis study in rats.
Ampe B; Massie A; D'Haens J; Ebinger G; Michotte Y; Sarre S
J Neurochem; 2007 Nov; 103(3):1063-74. PubMed ID: 17727638
[TBL] [Abstract][Full Text] [Related]
7. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.
Enna SJ; Reisman SA; Stanford JA
Neurosci Lett; 2006 Oct; 406(1-2):102-6. PubMed ID: 16890350
[TBL] [Abstract][Full Text] [Related]
8. Properties of dopaminergic neurons in organotypic mesencephalic-striatal co-cultures--evidence for a facilitatory effect of dopamine on the glutamatergic input mediated by α-1 adrenergic receptors.
Cucchiaroni ML; Freestone PS; Berretta N; Viscomi MT; Bisicchia E; Okano H; Molinari M; Bernardi G; Lipski J; Mercuri NB; Guatteo E
Eur J Neurosci; 2011 May; 33(9):1622-36. PubMed ID: 21453288
[TBL] [Abstract][Full Text] [Related]
9. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE
Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980
[TBL] [Abstract][Full Text] [Related]
10. NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways.
Fantin M; Marti M; Auberson YP; Morari M
J Neurochem; 2007 Dec; 103(6):2200-11. PubMed ID: 17986236
[TBL] [Abstract][Full Text] [Related]
11. The excitoprotective effect of N-methyl-D-aspartate receptors is mediated by a brain-derived neurotrophic factor autocrine loop in cultured hippocampal neurons.
Jiang X; Tian F; Mearow K; Okagaki P; Lipsky RH; Marini AM
J Neurochem; 2005 Aug; 94(3):713-22. PubMed ID: 16000165
[TBL] [Abstract][Full Text] [Related]
12. Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia.
Mueller HT; Haroutunian V; Davis KL; Meador-Woodruff JH
Brain Res Mol Brain Res; 2004 Feb; 121(1-2):60-9. PubMed ID: 14969737
[TBL] [Abstract][Full Text] [Related]
13. Neurodegenerative alterations in the nigrostriatal system of trkB hypomorphic mice.
Zaman V; Nelson ME; Gerhardt GA; Rohrer B
Exp Neurol; 2004 Dec; 190(2):337-46. PubMed ID: 15530873
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons.
Du F; Li R; Huang Y; Li X; Le W
Eur J Neurosci; 2005 Nov; 22(10):2422-30. PubMed ID: 16307585
[TBL] [Abstract][Full Text] [Related]
15. Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease.
Bonsi P; Cuomo D; Picconi B; Sciamanna G; Tscherter A; Tolu M; Bernardi G; Calabresi P; Pisani A
Amino Acids; 2007 Feb; 32(2):189-95. PubMed ID: 16715415
[TBL] [Abstract][Full Text] [Related]
16. Predominant surface distribution of neurokinin-3 receptors in non-dopaminergic dendrites in the rat substantia nigra and ventral tegmental area.
Lessard A; Grady EF; Bunnett NW; Pickel VM
Neuroscience; 2007 Feb; 144(4):1393-408. PubMed ID: 17197098
[TBL] [Abstract][Full Text] [Related]
17. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra.
Nosheny RL; Bachis A; Aden SA; De Bernardi MA; Mocchetti I
J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504
[TBL] [Abstract][Full Text] [Related]
18. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
Rouillon C; Degoulet M; Chevallier K; Abraini JH; David HN
Brain Res; 2008 Mar; 1198():44-54. PubMed ID: 18261716
[TBL] [Abstract][Full Text] [Related]
19. Functional alterations of the nigrostriatal dopamine system in estrogen receptor-alpha knockout (ERKO) mice.
Küppers E; Krust A; Chambon P; Beyer C
Psychoneuroendocrinology; 2008 Jul; 33(6):832-8. PubMed ID: 18472350
[TBL] [Abstract][Full Text] [Related]
20. Glial regulation of nonsynaptic extracellular glutamate in the substantia nigra.
Rodríguez Díaz M; Alonso TJ; Perdomo Diaz J; Gonzalez Hernández T; Castro Fuentes R; Sabate M; Garcia Dopico J
Glia; 2005 Jan; 49(1):134-42. PubMed ID: 15390097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
